Tori Whitacre Martonicz

Explore diabetic foot care insights with Gary M. Rothenberg, DPM, Director of Medical Affairs at Podimetrics. Learn about prevention, remote monitoring, and the multidisciplinary approach to mitigate the risks of amputations.

Explore eco-friendly cleaning with a focus on EPA certifications and eco-friendly cleaners' efficacy. Uncover real-world research insights and a review of an ISSA thought leader session.

In this final of 3 segments of an interview with ICT, Thomas Rademacher, Emergex co-founder, delves into T cell-based vaccines for chikungunya, likening immune programming to software, emphasizing the urgency of prevention in endemic regions.

Society for Healthcare Epidemiology of America/Infectious Diseases Society of America/Association for Professionals in Infection Control and Epidemiology answer Diekema, et al, about MRSA prevention strategies.

Joseph A. Ladapo, MD, PhD-ASTHO, calls for the halt of these vaccines; however, the FDA disagrees and says that “misinformation and disinformation about these vaccines…results in vaccine hesitancy.”

The FDA-approved vaccine for chikungunya is out, but is it a safer and more effective solution for preventing this infectious disease? What other options are coming? ICT finds out.

In a study released today on sepsis patients, limited English proficiency (LEP) didn't show a significant overall mortality link. However, LEP patients in the non-Hispanic White subgroup faced higher mortality rates.

Is it safe for individuals with psoriasis or eczema to get a tattoo, considering the possibility of the Koebner phenomenon?

Explore a musical journey through illness with our list of catchy songs about ailments. Plus, discover timeless blues classics that resonate with the human experience of sickness.

Explore a thrilling movie list featuring infectious diseases and zombie outbreaks, from "Contagion" to "World War Z," perfect for horror fans!

After pushback on social media, Tina Joshi, PhD, spoke with Infection Control Today to clarify and explain her study, her lifelong research, and what she hopes IPs and other IPC personnel can take from them.

Dr. Gail Gazelle's "Mindful MD" addresses health care burnout with mindfulness, imposter syndrome, and other issues offering practical solutions and strategies for health care professionals.

As tropical viruses increase in the US, Infection Control Today wanted to learn more about chikungunya. Here is what we learned.

Infection Control Today is proud to announce the winner of the Infection Control Today Educator of the Year Award: Sharon Ward-Fore, MS, BS, MT(ASCP), CIC, FAPIC. Listen to the announcement and interview with the winner.

Which of the various low and high-tech measures proposed to mitigate SARS-CoV-2 transmission, from hand hygiene to air cleaners, actually work? A new study gives practical tools for assessment and insights into their effectiveness.

A critical analysis questions the universal application of contact precautions (CP) for MRSA prevention, considering potential harms, environmental sustainability, and evidence-based alternatives.

Learn about vital vaccination recommendations during pregnancy to prevent respiratory diseases like RSV, COVID-19, and influenza. NFID's Robert H. Hopkins, Jr. MD, offers insights and strategies for effective communication.

A recent study from Chapel Hill, NC, shows some bloodstream infections are reduced by nearly 50% when trained nurse observers assist catheter insertion teams.

Explore how AION Biosystems' iTempShield, a skin-wearable device and software system, could transform infection monitoring for chemotherapy patients, enhancing early detection, and reducing hospitalizations.

This systematic review explores the role of robots and smart environments in infection prevention and control (IPC) within health care settings. A few advancements in IPC automation were identified, emphasizing the need for increased awareness and global accessibility.

The Texas Ambulatory Surgery Center Society (TASCS) hosts an annual infection prevention seminar to educate and support Texas ASCs. Learn about its significance and insights from experts.

For Thanksgiving, Infection Control Today® asked its Editorial Advisory Board what they're thankful for. From family to dreams coming true, they express gratitude for various aspects of life and work.

Mass General Brigham and Salem Hospital face a class action lawsuit over potential hepatitis and HIV exposure to hundreds of patients. The lawsuit alleges negligence and emotional distress, with the hospital claiming a minimal infection risk.

This interview with Cheron Rojo, BS, FCS, CHL, CIS, CER, CFER, CRCST, delves into a robust year-long study, starting in 2021, investigating the often-overlooked risks associated with insulated medical devices impacting both patients and medical staff.

Read about a cluster randomized clinical trial that found that direct gloving without prior hand hygiene significantly improved infection prevention practice adherence among health care personnel.

A recent study in a Hong Kong hospital investigated a rhinovirus outbreak and its transmission via air dispersal. The research aimed to improve understanding of rhinovirus transmission in health care settings. This article summarizes the study's findings and implications for infection control.

Read a literature review that examines methods for laundering reusable surgical scrubs. Discover the importance of water temperature, disinfectants, and more in infection control.

Recent CDC HICPAC revisions regarding SARS-CoV-2 control face criticism from the World Health Network and others due to alleged breaches in committee structure and erroneous infection control guidance, potentially impacting COVID-19 management and immunocompromised individuals in health care.

Kari A. Mergenhagen, PharmD, BCPS, BCIDP, discusses the potential of doxycycline in reducing C difficile infections among hospitalized patients with pneumonia. This interview delves into doxycycline's influence on patients with a prior C difficile history, demographic generalizability, exclusion criteria, and concerns regarding antibiotic resistance.

Pharmaceutical company Qnovia partners with the University of Virginia (UVA) to create inhaled drugs for lung infections, bolstering their development pipeline with assets for pneumonia and biodefense-related pulmonary infections.